Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,707 | -18,378 | -59,731 | -42,113 | -24,319 |
| Depreciation Amortization | 9,963 | 4,704 | 19,798 | 14,768 | 9,323 |
| Income taxes - deferred | N/A | N/A | -6,425 | -7,811 | -5,420 |
| Accounts receivable | 1,431 | 886 | 4,945 | 4,064 | 4,685 |
| Accounts payable and accrued liabilities | -2,811 | -9,330 | 2,060 | 425 | -3,458 |
| Other Working Capital | 1,309 | -6,405 | 3,814 | 2,984 | 958 |
| Other Operating Activity | 13,321 | 13,789 | 42,942 | 35,940 | 20,290 |
| Operating Cash Flow | $-17,494 | $-14,734 | $7,403 | $8,257 | $2,059 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 34,046 | -2,595 | 12,111 | 9,274 | 7,727 |
| PPE Investments | -601 | -39 | -887 | -1,437 | -1,056 |
| Purchase Of Investment | -15,000 | -10,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -11,389 | -8,217 | -13,122 | -9,632 | -6,278 |
| Other Investing Activity | -11,389 | -8,217 | 34,378 | 37,868 | 41,222 |
| Investing Cash Flow | $7,056 | $-20,851 | $45,602 | $45,705 | $47,893 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,030 | 4,864 | 11,732 | 11,340 | 3,003 |
| Other Financing Activity | -8,647 | -7,566 | -6,287 | -7,256 | -4,754 |
| Financing Cash Flow | $383 | $-2,702 | $5,445 | $4,084 | $-1,751 |
| Exchange Rate Effect | -34 | 10 | -58 | -57 | 63 |
| Beginning Cash Position | 99,394 | 99,394 | 41,002 | 41,002 | 41,002 |
| End Cash Position | 89,305 | 61,117 | 99,394 | 98,991 | 89,266 |
| Net Cash Flow | $-10,089 | $-38,277 | $58,392 | $57,989 | $48,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,494 | -14,734 | 7,403 | 8,257 | 2,059 |
| Capital Expenditure | -601 | -39 | -887 | -1,437 | -1,056 |
| Free Cash Flow | -18,095 | -14,773 | 6,516 | 6,820 | 1,003 |